PW Medtech Group Ltd (fra:PWE) Share Price

Company Profile

Business description
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments namely Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. It generates maximum revenue from Blood Purification Business. Geographically, it operates in China, North America, India and Others.
Contact
No. 23 Panlong West Road
Building 1
Pinggu District
Beijing101204
CHN
T: +86 1080910666
https://www.pwmedtech.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
1,356

Recommended

We doubt the $5 billion is meaningful enough to force Nvidia to use Intel, either for core products or even for the chips in collaboration.

Brian Colello, CPA | 19 September 2025

Our Fair Value estimate once again reflects the stand-alone business and its growth potential.

Mark Taylor | 19 September 2025

Coverage of ASX listed REIT as investor interest in property continues to grow.

Yingqi Tan, CFA | 19 September 2025

Index	Last price	Change	% Change
All Ordinaries	9,061.20	61.30	-0.67%
CAC 40	7,875.46	20.85	0.27%
DAX 40	23,652.10	22.43	-0.09%
Dow JONES (US)	46,142.42	124.10	0.27%
FTSE 100	9,232.84	4.73	0.05%
HKSE	26,545.10	106.59	0.40%
NASDAQ	22,470.72	209.40	0.94%
Nikkei 225	45,045.81	143.54	0.32%
NZX 50 Index	13,231.66	3.23	-0.02%
S&P 500	6,631.96	31.61	0.48%
S&P/ASX 200	8,773.50	75.00	-0.85%
SSE Composite Index	3,820.09	11.57	-0.30%